{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:23Z","timestamp":1786979963829,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001745","name":"Asia Pacific League of Associations for Rheumatology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001745","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00296-021-05063-3","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T19:05:35Z","timestamp":1642187135000},"page":"1143-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The prevalence and clinical characteristics of anti-HMGCR (anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) antibodies in idiopathic inflammatory myopathy: an analysis from the MyoCite registry"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-614X","authenticated-orcid":false,"given":"Arvind","family":"Nune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-3925","authenticated-orcid":false,"given":"R.","family":"Naveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0720-9371","authenticated-orcid":false,"given":"Ritu","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4270-8763","authenticated-orcid":false,"given":"Pallavi","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-2198","authenticated-orcid":false,"given":"Rajat","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1658-8155","authenticated-orcid":false,"given":"Upendra","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9450-5696","authenticated-orcid":false,"given":"Mohit Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-2182","authenticated-orcid":false,"given":"Mantabya Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-8756","authenticated-orcid":false,"given":"Anamika Kumari","family":"Anuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"issue":"3","key":"5063_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/RHU.0000000000001214","volume":"27","author":"H Muhammed","year":"2021","unstructured":"Muhammed H, Gupta L, Zanwar AA et al (2021) Infections are leading cause of in-hospital mortality in Indian patients with inflammatory myopathy. J Clin Rheumatol 27(3):114\u2013119","journal-title":"J Clin Rheumatol"},{"key":"5063_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/TCRM.S197941","volume":"16","author":"E Tiniakou","year":"2020","unstructured":"Tiniakou E (2020) Statin-associated autoimmune myopathy: current perspectives. Ther Clin Risk Manag 16:483\u2013492","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"5063_CR3","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G et al (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62(9):2757\u20132766","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5063_CR4","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","volume":"6","author":"P Mohassel","year":"2018","unstructured":"Mohassel P, Landon-Cardinal O, Foley AR et al (2018) Anti-HMGCR myopathy may resemble limb\u2013girdle muscular dystrophy. Neurol Neuroimmunol Neuroinflamm 6(1):e523","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"5063_CR5","first-page":"787","volume":"56","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou E, Pinal-Fernandez I, Lloyd TE et al (2017) More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford) 56(5):787\u2013794","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"5063_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","volume":"56","author":"WC Liang","year":"2017","unstructured":"Liang WC, Uruha A, Suzuki S et al (2017) Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies. Rheumatology (Oxford) 56(2):287\u2013293","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"5063_CR7","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","volume":"2","author":"A Alshehri","year":"2015","unstructured":"Alshehri A, Choksi R, Bucelli R et al (2015) Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm 2(4):e124","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"5063_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/ana.24902","volume":"81","author":"L Arouche-Delaperche","year":"2017","unstructured":"Arouche-Delaperche L, Allenbach Y, Amelin D et al (2017) Pathogenic role of anti-signal recognition protein and anti-3-hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol 81(4):538\u2013548","journal-title":"Ann Neurol"},{"issue":"1","key":"5063_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/JND-170282","volume":"5","author":"P Mohassel","year":"2018","unstructured":"Mohassel P, Mammen AL (2018) Anti-HMGCR myopathy. J Neuromuscul Dis 5(1):11\u201320","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"5063_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13075-019-2093-6","volume":"22","author":"A Meyer","year":"2020","unstructured":"Meyer A, Troyanov Y, Drouin J et al (2020) Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients. Arthritis Res Ther 22(1):5","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5063_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/annrheumdis-2018-213518","volume":"78","author":"C Bergua","year":"2019","unstructured":"Bergua C, Chiavelli H, Allenbach Y et al (2019) In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy. Ann Rheum Dis 78(1):131\u2013139","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5063_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/injr.injr_95_20","volume":"15","author":"R Naveen","year":"2020","unstructured":"Naveen R, Anuja A, Rai M et al (2020) Development of the MyoCite biobank: cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis. Indian J Rheumatol 15(6):194\u2013199","journal-title":"Indian J Rheumatol"},{"issue":"2","key":"5063_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/injr.injr_40_19","volume":"14","author":"L Gupta","year":"2019","unstructured":"Gupta L, Appani S, Janardana R et al (2019) Meeting report: MyoIN & #8211; Pan-India collaborative network for myositis research. Indian J Rheumatol 14(2):136\u2013142","journal-title":"Indian J Rheumatol"},{"issue":"11","key":"5063_CR14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van den Hoogen","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J et al (2013) Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131755","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5063_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.semarthrit.2020.10.014","volume":"51","author":"L Gupta","year":"2021","unstructured":"Gupta L, Naveen R, Gaur P et al (2021) Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis. Semin Arthritis Rheum 51(1):113\u2013120","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"5063_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/injr.injr_102_20","volume":"15","author":"P Mehta","year":"2020","unstructured":"Mehta P, Gupta L (2020) Combined case record forms for collaborative datasets of patients and controls of idiopathic inflammatory myopathies. Indian J Rheumatol 15(6):191\u2013193","journal-title":"Indian J Rheumatol"},{"issue":"3","key":"5063_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","volume":"93","author":"Y Allenbach","year":"2014","unstructured":"Allenbach Y, Drouot L, Rigolet A et al (2014) Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 93(3):150\u2013157","journal-title":"Medicine (Baltimore)"},{"key":"5063_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10621-7","author":"Y Hou","year":"2021","unstructured":"Hou Y, Shao K, Yan Y et al (2021) Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy. J Neurol. https:\/\/doi.org\/10.1007\/s00415-021-10621-7","journal-title":"J Neurol"},{"issue":"44","key":"5063_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005280","volume":"95","author":"M Hudson","year":"2016","unstructured":"Hudson M, Luck Y, Stephenson M et al (2016) Anti-HMGCR antibodies in systemic sclerosis. Medicine 95(44):e5280. https:\/\/doi.org\/10.1097\/MD.0000000000005280","journal-title":"Medicine"},{"key":"5063_CR20","first-page":"2050313X2098412","volume":"8","author":"D Lim","year":"2020","unstructured":"Lim D, Landon-Cardinal O, Ellezam B et al (2020) Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: a case report. SAGE Open Med Case Rep 8:2050313X20984120","journal-title":"SAGE Open Med Case Rep"},{"issue":"5","key":"5063_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/03009742.2019.1672782","volume":"49","author":"R Aggarwal","year":"2020","unstructured":"Aggarwal R, Moghadam-Kia S, Lacomis D et al (2020) Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level. Scand J Rheumatol 49(5):405\u2013411","journal-title":"Scand J Rheumatol"},{"key":"5063_CR22","doi-asserted-by":"publisher","first-page":"102691","DOI":"10.1016\/j.jaut.2021.102691","volume":"123","author":"B Williams","year":"2021","unstructured":"Williams B, Horn MP, Banz Y et al (2021) Cutaneous involvement in anti-HMGCR positive necrotizing myopathy. J Autoimmun 123:102691","journal-title":"J Autoimmun"},{"key":"5063_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04897-1","author":"SK Dunga","year":"2021","unstructured":"Dunga SK, Kavadichanda C, Gupta L et al (2021) Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-04897-1","journal-title":"Rheumatol Int"},{"issue":"7","key":"5063_CR24","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1093\/rheumatology\/keaa821","volume":"60","author":"U Rathore","year":"2021","unstructured":"Rathore U, Haldule S, Gupta L (2021) Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis. Rheumatology (Oxford) 60(7):3483","journal-title":"Rheumatology (Oxford)"},{"key":"5063_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.23113","volume":"69","author":"T Kishi","year":"2017","unstructured":"Kishi T, Rider LG et al (2017) Association of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care Res 69:1088\u20131094","journal-title":"Arthritis Care Res"},{"key":"5063_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.160871","volume":"44","author":"SL Tansley","year":"2017","unstructured":"Tansley SL et al (2017) Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients. J Rheumatol 44:488\u2013492","journal-title":"J Rheumatol"},{"issue":"3","key":"5063_CR27","doi-asserted-by":"publisher","first-page":"adv00415","DOI":"10.2340\/00015555-3645","volume":"101","author":"C Scard","year":"2021","unstructured":"Scard C, Bara-Passot C, Chassain K et al (2021) Unusual skin involvement in statin-induced anti-HMGCR immune-mediated necrotizing myopathy. Acta Derm Venereol 101(3):adv00415","journal-title":"Acta Derm Venereol"},{"issue":"8\u20139","key":"5063_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.annder.2018.12.010","volume":"146","author":"M Merlant","year":"2019","unstructured":"Merlant M, Fite C, Kottler D et al (2019) Myopathie n\u00e9crosante auto-immune \u00e0 anticorps anti-HMGCR induite par les statines et r\u00e9v\u00e9l\u00e9e par un tableau \u00e9vocateur de dermatomyosite [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies]. Ann Dermatol Venereol 146(8\u20139):550\u2013556","journal-title":"Ann Dermatol Venereol"},{"key":"5063_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10067-017-3831-2","volume":"37","author":"MJ Waters","year":"2018","unstructured":"Waters MJ, Limaye V (2018) Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort. Clin Rheumatol 37:543\u2013547","journal-title":"Clin Rheumatol"},{"key":"5063_CR30","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s10067-019-04756-2","volume":"38","author":"K Yongchairat","year":"2019","unstructured":"Yongchairat K, Tanboon J, Waisayarat J et al (2019) Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study. Clin Rheumatol 38:3459\u20133469","journal-title":"Clin Rheumatol"},{"key":"5063_CR31","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00296-020-04695-1","volume":"40","author":"L Gupta","year":"2020","unstructured":"Gupta L, Muhammed H, Naveen R et al (2020) Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians. Rheumatol Int 40:2047\u20132055","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-05063-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T05:09:45Z","timestamp":1655356185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-05063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5063"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-05063-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was obtained from the Institute Ethics Committee (2021-34-IP-EXP-36) of SGPGIMS, Lucknow, as per local guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval information"}}]}}